Rincon Bio performs SK-BR-3 xenograft models to test efficacy of preclinical therapies. Please see below for additional information or to request a quote.
Organism: Homo sapiens, human / Tissue: mammary gland/breast; derived from metastatic site: pleural effusion / Disease: adenocarcinoma
This cell line was derived by G. Trempe and L. J. Old in 1970 from pleural effusion cells of a patient, a White, Caucasian female, age 43, blood type A+, who had been treated with radiation, steroids, cytoxan and 5-fluorouracil. Ref
Forms tumors in nude mice
Used in xenografts to test the efficacy of novel cancer therapeutics
Rincon Bio Growth Curve
Cell Line: SK-BR-3
Mouse Strain: Nude
Cells Implanted per Animal: 5 million
WHY WORK WITH
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
SPEED TO INITIATION
Most efficacy studies can be initiated within two business days.
We love our clients! We are easy to work with. And we take a personal interest in our clients and their studies.